Eli Lilly and Company Price Today
Eli Lilly and Company
LLY
Healthcare
$739.02B
💰
Market Cap
133.3
💸
Price to Earnings
$5.8
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
15 |
Strong Buy |
9 |
Hold |
8 |
Sell |
0 |
Strong Sell |
0 |
LLY Price Forecast Target
777.3 👉 901.6 +16%
LLY EPS Forecast
5.8 👉 16.5 +182%
Financials
Profit Margin
15 %
Revenue Growth
28.1 %
Dividend
$ 5.2
Held Percent
0.2% - Insiders
84.3% - Institutions
15.5% - Public
Major Fund Holders
-
💰 $
-
💰 $
-
💰 $
-
💰 $
-
💰 $
Stock Ideas
Carl Icahn Portfolio
With a staggering net worth exceeding $16 billion, Icahn has made a lasting impact on the stock market as the founder and manager of Icahn Enterprises. Known as a 'corporate raider,' Icahn has gained fame for his relentless pursuit of undervalued co…
Nelson Peltz Portfolio
Nelson Peltz is a renowned investor known for his astute investment strategies and activist approach. With a portfolio spanning diverse industries, Peltz strategically targets underperforming companies, advocating for changes that unlock their full …
Israel Englander Portfolio
Israel Englander, a notable figure in the finance industry, began his journey by obtaining his undergraduate degree from NYU before venturing into trading on the American Stock Exchange (AMEX), where he found early success. In 1989, he went on to es…
Charlie Munger Portfolio
Charlie Munger, the renowned investor and Vice Chairman of Berkshire Hathaway, is a true titan in the world of finance. Often referred to as Warren Buffett's right-hand man, Munger's portfolio investment approach is a masterclass in disciplined and …📮FAQ
Some Frequently Asked Questions.
The Eli Lilly and Company industry is Drug Manufacturers—General
The Eli Lilly and Company sector is Healthcare
The Eli Lilly and Company forecasted predicted Price to Earnings PE ratio is 47.2
The Eli Lilly and Company Price to Earnings PE ratio is 133.3
The Market Capitalization of Eli Lilly and Company is $739.02B
There are total of 897860031 float shares with 84.3% held by Institutions and 0.2% held by insiders
The MEli Lilly and Company forecasted Earnings per Share EPS is $16.5
The Eli Lilly and Company Earnings per Share EPS is 5.8
The Eli Lilly and Company company has $0 gross profits with 15 profit margins
The Eli Lilly and Company Earnings Growth is 0.13% with 0.13% quarterly earnings growth
The Eli Lilly and Company Revenue is $34124099584 with 0.281 revenue growth
The price target for Eli Lilly and Company stock is $901.6 for the high target and $486.9 for the low target
The consensus analyst recommendations for Eli Lilly and Company is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for Eli Lilly and Company is Buy, with the following breakdown:
- Buy: 15
- Strong Buy: 9
- Hold: 8
- Sell: 0
- Strong Sell: 0
The Beta of Eli Lilly and Company is 0.4
The dividend of Eli Lilly and Company is $5.2
The dividend yield of Eli Lilly and Company is 0.0067000003%
The biggest institutional and mutual fund holders of Eli Lilly and Company stock are
The Eli Lilly and Company ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0